190 related articles for article (PubMed ID: 4686009)
1. Role of brain norepinephrine in audiogenic seizure in the rat.
Jobe PC; Picchioni AL; Chin L
J Pharmacol Exp Ther; 1973 Jan; 184(1):1-10. PubMed ID: 4686009
[No Abstract] [Full Text] [Related]
2. Role of brain 5-hydroxytryptamine in audiogenic seizure in the rat.
Jobe PC; Picchioni AL; Chin L
Life Sci; 1973 Jul; 13(1):1-13. PubMed ID: 4270954
[No Abstract] [Full Text] [Related]
3. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines.
Rech RH; Carr LA; Moore KE
J Pharmacol Exp Ther; 1968 Apr; 160(2):326-35. PubMed ID: 5651375
[No Abstract] [Full Text] [Related]
4. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.
Azzaro AJ; Wenger GR; Craig CR; Stitzel RE
J Pharmacol Exp Ther; 1972 Mar; 180(3):558-68. PubMed ID: 4258979
[No Abstract] [Full Text] [Related]
5. Comparison of the effectiveness of deserpidine, reserpine, and alpha-methyltyrosine on brain biogenic amines.
Fulton SC; Healy MD
Fed Proc; 1976 Dec; 35(14):2558-62. PubMed ID: 11134
[No Abstract] [Full Text] [Related]
6. The effect of reserpine, alpha-methyl-m-tyrosine, prenylamine, and guanethidine on metrazol-convulsions and the brain monoamine level in mice.
Pfeifer AK; Galambos E
Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):201-11. PubMed ID: 6030237
[No Abstract] [Full Text] [Related]
7. Effect of drugs on animals exposed to chronic environmental stress.
Smookler HH; Buckley JP
Fed Proc; 1970; 29(6):1980-4. PubMed ID: 5482721
[No Abstract] [Full Text] [Related]
8. Genetics of audiogenic seizures. 3. Time response relationships between drug administration and seizure susceptibility.
Schlesinger K; Boggan WO; Freedman DX
Life Sci I; 1970 Jul; 9(13):721-9. PubMed ID: 4394568
[No Abstract] [Full Text] [Related]
9. The effect of imipramine on central monoamine neurons.
Corrodi H; Fuxe K
J Pharm Pharmacol; 1968 Mar; 20(3):230-1. PubMed ID: 4385053
[No Abstract] [Full Text] [Related]
10. Histochemical fluorescence detection of changes in central monoamine neurones provoked by drugs acting on the CNS.
Fuxe K; Hökfelt T
Triangle; 1971; 10(3):73-84. PubMed ID: 5138525
[No Abstract] [Full Text] [Related]
11. The effect of acute and prolonged cold exposure on the brain amine depleting action of reserpine.
Ingenito AJ
Arch Int Pharmacodyn Ther; 1967 Apr; 166(2):324-32. PubMed ID: 5298460
[No Abstract] [Full Text] [Related]
12. [Correlation between seizure susceptibility and brain catecholamine levels. An experimental study using a kindling preparation].
Sato M; Nakashima T; Mitsunobu K; Otsuki S
No To Shinkei; 1976 May; 28(5):471-7. PubMed ID: 140696
[TBL] [Abstract][Full Text] [Related]
13. The effects of two inhibitors of catecholamine synthesis on the content of noradrenaline and dopamine of the rat brain.
Goodchild MA; Brownlee G
Br J Pharmacol; 1969 May; 36(1):203P-204P. PubMed ID: 5768113
[No Abstract] [Full Text] [Related]
14. Audiogenic seizures in rats: relation to noradrenergic neurons of the locus coeruleus.
Jerlicz M; Kostowski W; Bidziński A; Hauptman M; Dymecki J
Acta Physiol Pol; 1978; 29(5):409-12. PubMed ID: 747102
[TBL] [Abstract][Full Text] [Related]
15. Role of catecholamines in the central effects of amphetamine.
Pfeifer AK; György L; Fodor M
Acta Med Acad Sci Hung; 1968; 25(3):441-50. PubMed ID: 5720870
[No Abstract] [Full Text] [Related]
16. Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
Boggan WO; Seiden LS
Physiol Behav; 1971 Mar; 6(3):215-7. PubMed ID: 5125476
[No Abstract] [Full Text] [Related]
17. Plasma corticosterone changes following alterations in brain norepinephrine and serotonin.
McKinney WT; Prange AJ; Majchowicz E; Schlesinger K
Dis Nerv Syst; 1971 May; 32(5):308-13. PubMed ID: 4397134
[No Abstract] [Full Text] [Related]
18. Letter: Effect of lithium carbonate and alpha-methyl-p-tyrosine on audiogenic seizure intensity.
Jobe PC; Picchioni AL; Chin L
J Pharm Pharmacol; 1973 Oct; 25(10):830-1. PubMed ID: 4149748
[No Abstract] [Full Text] [Related]
19. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
Beuthin FC; Miya TS; Blake DE; Bousquet WF
J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
[No Abstract] [Full Text] [Related]
20. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
Cooper BR; Breese GR; Grant LD; Howard JL
J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
[No Abstract] [Full Text] [Related]
[Next] [New Search]
